Extremophiles: From Biology to Biotechnology

ISBN-13: 9780367572327 / Angielski / Miękka / 2020 / 399 str.

Ravi V. Durvasula; D. V. Subba Rao

Opis

Extremophiles: From Biology to Biotechnology comprehensively covers the basic biology, physiology, habitats, secondary metabolites for bioprospecting, and biotechnology of these extreme survivors. The chapters focus on the novel genetic and biochemical traits that lend these organisms to biotechnological

Spis treści

Extremophiles: Introduction. Diversity and Taxa. Chlorophylls and Pigments. Culturing Autotrophic Extremophiles – Growth Rates. Culturing Heterotrophic Extremophiles- Growth Rates. Antarctic Extremophiles. Osmosis. Salinity Stress. Allelopathy. Temperature -Extreme Low Temp. Temp. Heat Resistant. Psychrophillic Photosyn. Photo Heterotrophy. UV Radiation Impacts. Biochem P:N:C. Marine Enzymes. Fatty Acids and Lipids. Biliproteins. Source of Proteins. Metabolites/Metabolomics. Extremolytes. Valuable Products. Natural Compounds. Wastewater Cultivation. Bioremediation. Transesterification. Paratransgenics. Transgenics. Genomics. Biotechnological Applications. Emerging Fields.

O autorze

Subba Rao V. Durvasula was awarded the degree of Doctor of Philosophy from the Andhra University. His scientific career engaged him first as a UNESCO Fellow and subsequently as a scientist at the CSIRO (Commonwealth Scientific and Industrial Research Organization) Australia, NRC Fellow (National Research Council of Canada, Bedford Inst. Oceanography, Canada), Faculty member of The John’s Hopkins University, U.S.A, as a Biological Oceanographer at the BIO and later as an Emeritus Scientist (Bedford Institute of Oceanography,Dartmouth, Canada), as an Adjunct Professor at the University of New Mexico, and, at present, a Consultant scientist at the Kuwait Institute for Scientific Research, Kuwait.

Dr. Ravi Durvasula is a Professor of Medicine and Infectious Diseases at University of New Mexico School of Medicine in Albuquerque, New Mexico, where he is also appointed as Chief of Medicine at the New Mexico VA Health Care System. Dr. Durvasula's laboratory focuses on transgenic and paratransgenic approaches to control of vector-borne diseases such as Chagas disease and Leishmaniasis. He currently has collaborative research programs in Brazil, Guatemala, Argentina and India. Dr. Durvasula's research also involves development of novel paratransgenic delivery systems for application at human mucosal surfaces.